Terrain Bio Inks Headquarters Lease in Cambridge Innovation Corridor
Phase 3 Real Estate Partners, Inc. has announced that Terrain Bio, a cutting-edge biotech company specializing in the integration of AI, automated cell biology, and large-scale biobanks for drug discovery, has signed a lease for its new headquarters at GENESIS 640 Memorial Drive. This prominent life science development is located within Cambridge’s renowned innovation corridor. Although the lease terms remain undisclosed, it marks a significant milestone following the successful delivery of the final move-in-ready lab suites at the property.
“Terrain Bio represents the kind of pioneering science that thrives in the Cambridge ecosystem,” said Morgan Weinstein, Vice President at Phase 3 Real Estate Partners. “Their decision to establish their headquarters at GENESIS 640 Memorial Drive reinforces not only the vitality of this market but also our broader commitment to delivering flexible, high-performance lab space across the GENESIS portfolio.”
CBRE acted as the representative for Phase 3 Real Estate Partners, while Colliers provided tenant representation for Terrain Bio.
